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ANNOUNCEMENT 
A two-day international conference "Pharmacologic Intervention in the Ageing Process" will 
be convened by Prof. A. Kligman, University of Pennsylvania, in London, September 26-27, 
1994. 
For further details, please contact either Jackie Ford or John Jennings, MAIC Ltd, Croxted 
Mews, 286A-288 Croxted Road, London SE24 9BY, UK. Tel, ++44 (0) 81-671-7521; Fax, 
++44 (0) 81-671-7327. 
